Venture capitalists have valued the telehealth business at $500 million after various fundraising series since the company launched in 2017, according to the report.
Ro is the parent company of telehealth apps Roman, which provides services for men experiencing issues like erectile dysfunction, as well as Rory, which comprises products for menopausal women.
The telehealth parent also leads a digital health brand, called Zero, which aims to help customers quit smoking. Zero offers prescription cessation medication as well as a mobile app for users to track their progress.
More articles on telehealth:
Ocular telemedicine company sues Indiana over prohibition of at-home vision tests
Ochsner to offer patients physical exam device for telehealth appointments
pMD launches HIPAA-compliant video chat, messaging service
